Prevention of stroke for clinical purposes

被引：0
作者：
Grotemeyer, K-H. [1 ]
Grotemeyer, K. C. [1 ]
机构：
[1] Klinikum Saarbrucken, Neurol Klin, D-66119 Saarbrucken, Germany
来源：
NERVENHEILKUNDE | 2009年 / 28卷 / 11期
关键词：
Stroke; secondary prevention; aggregation inhibitors; anti-coagulation; costs; ACETYLSALICYLIC-ACID; SECONDARY PREVENTION; ATRIAL-FIBRILLATION; DOUBLE-BLIND; ASPIRIN; CLOPIDOGREL; TRIAL; RISK; DIPYRIDAMOLE; ATORVASTATIN;
D O I：
10.1055/s-0038-1627161
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The physician knows the guidelines from the German Neurology Society (DGN) for the prevention of a second stroke. However, for the treatment of a patient pragmatism is necessary and the costs for the system have to be regarded. Furthermore, clinical studies can leave unanswered questions. For the choice of the aggregation inhibitor the individual situation of the patient should be regarded. Blood pressure has to be observed and regulated. Lipid-lowering agents are effective for elderly patients as prevention, but not as first choice treatment. For every medical treatment, practical and clinical usefulness should be regarded.
引用
收藏
页码：789 / +
页数：6
相关论文
共 50 条
  • [1] UPDATE ON ANTITHROMBOTIC AGENTS IN SECONDARY STROKE PREVENTION
    Rundek, Tatjana
    Basic-Kes, Vanja
    Morovic, Sandra
    Demarin, Vida
    ACTA CLINICA CROATICA, 2011, 50 (01) : 101 - 106
  • [2] Antiplatelets in Stroke Prevention
    Pinto, Antonio
    Di Raimondo, Domenico
    Tuttolomondo, Antonino
    Butta, Carmelo
    Licata, Giuseppe
    CURRENT VASCULAR PHARMACOLOGY, 2013, 11 (06) : 803 - 811
  • [3] Secondary Stroke Prevention with Antithrombotic Drugs
    De Schryver, Els Lisette Leo Maria
    Algra, Ale
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (01) : 129 - 133
  • [4] Secondary stroke prevention in patients with diabetes mellitus
    Weber, R.
    Busch, K.
    Diener, H. C.
    DIABETOLOGE, 2009, 5 (08): : 620 - +
  • [5] Antiplatelet Agents for Stroke Prevention
    Yip, Samuel
    Benavente, Oscar
    NEUROTHERAPEUTICS, 2011, 8 (03) : 475 - 487
  • [6] Platelet Antiaggregants in Stroke Prevention
    Vidal, Sarkis G. Morales
    Ruland, Sean
    NEUROLOGIC CLINICS, 2013, 31 (03) : 633 - +
  • [7] Dual antiplatelet therapy for secondary stroke prevention in patients with acute ischemic stroke. CIERTO group recommendation
    Izcovich, Ariel
    Caruso, Diego
    Tisi Bana, Matias
    Bottaro, Federico
    Pollan, Javier
    Saavedra, Ezequiel
    Catalano, Hugo N.
    MEDICINA-BUENOS AIRES, 2019, 79 (04) : 315 - 321
  • [8] Use of Cilostazol for Secondary Stroke Prevention: An Old Dog with New Tricks?
    Ansara, Alexander J.
    Shiltz, Dane L.
    Slavens, Jennifer B.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 394 - 402
  • [9] Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice
    Tanislav, Christian
    Milde, Sonja
    Schwartzkopff, Sabine
    Sieweke, Nicole
    Kraemer, Heidrun Helga
    Juenemann, Martin
    Misselwitz, Bjoern
    Kaps, Manfred
    BMC NEUROLOGY, 2014, 14
  • [10] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Thomson, Ruth M.
    Anderson, David C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (02)
12345